Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

SensiumVitals® expands distribution network

26 Mar 2014 07:00

RNS Number : 1876D
Toumaz Limited
26 March 2014
 



 

RNS REACH

26 March 2014

 

Toumaz Limited

SensiumVitals® expands international distribution network

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in ultra-low power wireless semiconductor technology, announces that Sensium Healthcare, its wireless healthcare division, has extended the sales reach of its SensiumVitals® vital signs monitor to 12 countries.

Sensium Healthcare has recruited its own highly experienced direct sales force in the UK, France and Germany. The company has also executed distribution agreements for another four territories in Scandinavia (Sweden, Norway and Denmark) and the Middle East (Bahrain).

Along with existing agreements in the USA, Canada, Mexico, Australia and New Zealand, SensiumVitals® now has distribution in countries which collectively account for 60% of global healthcare spend. The company has also received regulatory clearance for SensiumVitals® in Australia.

With this development of its sales and distribution networks, Sensium Healthcare is embarking on full commercialisation of the SensiumVitals® system. The company is currently in discussions with over 60 hospitals worldwide.

Anthony Sethill, CEO of Toumaz Group, said:

"In the last six months, we have established an experienced and highly effective international sales platform for SensiumVitals®.

Initial customer engagements have been very encouraging. SensiumVitals® is positioned as a "game changer" for patient safety and healthcare economics - and it is proving a compelling proposition with both clinicians and hospital managers.

In 2014, we expect a significant ramp up in Sensium Healthcare's revenues - as discussions already under way with hospitals in Europe, North America and Australia lead to deployments in all of those regions."

Enquiries:

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Instinctif Partners

+44 (0)20 7457 2056

Adrian Duffield/Rozi Morris/Kathy Gordon

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The Group has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chip, modules and software for digital radio and connected audio devices.

About SensiumVitals®

SensiumVitals® is an ultra-low power system for wireless monitoring of patient vital signs, including heart rate, temperature and respiration. Measurements are taken every two minutes, rather than every four to eight hours, as currently standard in general wards. Patient data is then sent wirelessly and securely to clinicians via hospital IT systems. 

The key benefit of SensiumVitals® is that it provides clinicians with rapid warnings of patient deterioration, which in turn allows for earlier interventions, shorter stays in hospital and lower healthcare costs. 

For more information, see http://www.sensium-healthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASEIFUIFLSEID
Date   Source Headline
8th Jul 20097:00 amPRNPlacing
26th Jun 20091:32 pmPRNAnnual Report and Accounts
22nd Jun 20097:00 amPRNFinal Results
2nd Jun 20092:37 pmRNSHolding(s) in Company
26th May 20099:41 amPRNCorrection: Total Voting Rights
26th May 20099:17 amPRNTotal Voting Rights and Directors' Shareholding
21st May 20094:30 pmRNSHolding(s) in Company
20th May 20097:00 amPRNDirectorate Change
15th May 20097:00 amPRNPlacing, Imagination Shareholding, Chairman Appointment
14th May 200911:35 amPRNResult of EGM
6th May 20097:02 amPRNTechnical Milestone
27th Apr 20097:00 amRNSExtend Relationship
27th Apr 20097:00 amPRNNotice of EGM, Acquisition, Licensing Deal and Placing
14th Apr 20097:00 amPRNDisposal of 76.25% of Sentinel Healthcare Solutions
25th Mar 20097:00 amPRNFuture Waves Achieves Volume Production
16th Feb 200911:23 amPRNDirectorate Change
26th Jan 20094:21 pmPRNPlacing
15th Jan 20097:00 amPRNAcquisition of Majority Shareholding
6th Jan 20092:11 pmPRNStatement re Share Price Movement
26th Nov 20087:00 amPRNPlacing and Directors' Shareholdings
16th Oct 20087:00 amPRNPlacing
9th Oct 20082:54 pmPRNChange of Name to Toumaz Holdings Limited
29th Sep 20087:00 amPRNDirectorate Change
26th Sep 20084:53 pmPRNRe: Change of Name
26th Sep 20081:36 pmPRNResult of EGM and Change of Name
15th Sep 20087:00 amPRNHalf-yearly Report
10th Sep 20087:00 amPRNInfineon Licensing Agreement
3rd Sep 200812:45 pmPRNNotice of EGM - Correction
3rd Sep 20087:00 amPRNNotice of EGM
19th Aug 20087:00 amPRNChange of Adviser
14th Jul 20087:00 amRNSSentinel Signs Second Distrib
7th Jul 20082:55 pmRNSResult of AGM
4th Jul 20087:00 amPRNToumaz Signs Sensium Sports Licensing Agreement
11th Jun 200810:56 amRNSAnnual Report and Accounts
10th Jun 20087:00 amRNSMyAmego First Contract Win
12th May 20087:00 amPRNFuture Waves Completes US$4.75m Fundraising
6th May 20087:03 amRNSMyAmego Product Launch
11th Apr 20089:10 amRNSEC Grant Consortium Win
20th Mar 20087:00 amPRNFinal Results
18th Mar 20089:31 amPRNTexas Instrument's Agreement
4th Mar 200812:35 pmRNSHolding(s) in Company
4th Feb 200810:34 amPRNHolding(s) in Company
24th Jan 20087:00 amPRNSensium ISO Certification
22nd Jan 20087:00 amPRNChange of Adviser
12th Dec 20077:00 amPRNPatent Grant
30th Nov 20077:00 amPRNStrategic Alliance
26th Sep 20077:00 amPRNHalf-yearly Report
20th Sep 20075:27 pmPRNResult of AGM
17th Aug 20072:45 pmPRNAIM Rule 26 Compliance
17th Jul 20077:00 amPRNInstitutional Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.